Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 223,046
  • Shares Outstanding, K 91,039
  • Annual Sales, $ 50,580 K
  • Annual Income, $ -7,870 K
  • 60-Month Beta 2.81
  • Price/Sales 4.68
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AQST with:

Options Overview Details

View History
  • Implied Volatility 280.10% ( +174.55%)
  • Historical Volatility 50.58%
  • IV Percentile 91%
  • IV Rank 30.94%
  • IV High 807.70% on 11/14/23
  • IV Low 43.68% on 06/13/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 330
  • Volume Avg (30-Day) 282
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 15,962
  • Open Int (30-Day) 21,065

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.11
  • Number of Estimates 5
  • High Estimate -0.09
  • Low Estimate -0.14
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.24 +8.04%
on 06/26/24
3.10 -21.94%
on 06/03/24
-0.46 (-15.97%)
since 05/31/24
3-Month
2.24 +8.04%
on 06/26/24
4.54 -46.70%
on 04/19/24
-1.72 (-41.55%)
since 04/02/24
52-Week
1.25 +93.38%
on 10/06/23
6.23 -61.16%
on 03/18/24
+0.77 (+46.67%)
since 06/30/23

Most Recent Stories

More News
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics: Q4 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics: Q2 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics: Q4 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space

Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...

AQST : 2.42 (-1.22%)
Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Transcript

AQST earnings call for the period ending June 30, 2022.

AQST : 2.42 (-1.22%)
Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Completed EPIPHAST trial successfully demonstrating rapid and significant epinephrine exposure under a variety of real-world conditions after...

AQST : 2.42 (-1.22%)

Business Summary

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 2.53
2nd Resistance Point 2.49
1st Resistance Point 2.45
Last Price 2.42
1st Support Level 2.37
2nd Support Level 2.33
3rd Support Level 2.29

See More

52-Week High 6.23
Fibonacci 61.8% 4.33
Fibonacci 50% 3.74
Fibonacci 38.2% 3.15
Last Price 2.42
52-Week Low 1.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar